Assessment of Metformin as an Additional Treatment to Therapeutic Lifestyle Changes in Pediatric Patients with Metabolic Syndrome

Table 1

Participant characteristics.

	M group	C group	𝑃 value
Number of participants	30	30
Average age (yr)	13.2	13.2	1.0
Gender
Female %	46.7	46.7
Male %	53.3	53.3
Ethnicity
Hispanic %	76.7	76.7
Non-hispanic White %	23.3	20
Non-hispanic Black %	0	3.3
Treatment duration (days)	303	469	0.04
Avg. metformin dose (mg/daily)	1033.3	0